Inveresk Research Group

Inveresk Research Group was a leading global contract research organization (CRO) providing a broad range of drug development services to the pharmaceutical, biotechnology, and medical device industries. The company specialized in preclinical safety assessments, clinical trial management (Phase I-IV), and laboratory services. Headquartered in North Carolina with significant operations in Scotland, Inveresk supported clients through the entire drug development lifecycle. In 2004, the company was acquired by Charles River Laboratories in a deal valued at approximately $1.5 billion, significantly expanding Charles River's clinical and preclinical service capabilities.